Abstract:OBJECTIVETraumatic brain injury (TBI) is a major cause of long-term disability and death in young adults. The lack of pharmaceutical therapy for post-acute TBI recovery remains a crucial medical challenge. Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF), which are 2 key hematopoietic growth factors, have shown neuroprotective and neurorestorative effects in experimental stroke. The objective of this study was to determine the therapeutic efficacy of combined treatment (SCF + G-CSF) in subacute TBI.METHODSYoung-adult male C57BL mice were subject to TBI in the cortex of the right hemisphere. After TBI induction, mice were randomly divided into 2 groups: a vehicle control group and an SCF + G-CSF treatment group. Mice without TBI served as sham operative controls. Treatment was initiated 2 weeks after TBI induction. SCF (200 μg/kg) and G-CSF (50 μg/kg) or an equal volume of vehicle solution was subcutaneously injected daily for 7 days. A battery of neurobehavioral tests for evaluation of memory and cognitive function (water maze and novel object recognition tests), anxiety (elevated plus maze test), and motor function (Rota-Rod test) was performed during the period of 2-9 weeks after treatment. Neurodegeneration and dendritic density in both hemispheres were determined through histochemistry and immunohistochemistry at 11 weeks posttreatment.RESULTSWater maze testing showed that TBI-impaired spatial learning and memory was restored by SCF + G-CSF treatment. The findings from the elevated plus maze tests revealed that SCF + G-CSF treatment recovered TBI-caused anxiety and risk-taking behavior. There were no significant differences between the treated and nontreated TBI mice in both the Rota-Rod test and novel object recognition test. In the brain sections, the authors observed that widespread degenerating neurons were significantly increased in both hemispheres in the TBI-vehicle control mice. TBI-induced increases in neurodegeneration were significantly reduced by SCF + G-CSF treatment in the contralateral hemisphere, making it no different from that of the sham controls. Dendritic density in the frontal cortex of the contralateral hemisphere was significantly reduced in the TBI-vehicle control mice, whereas SCF + G-CSF-treated TBI mice showed significant increases of the dendritic density in the same brain region. SCF + G-CSF-treated TBI mice also showed a trend toward increasing dendritic density in the contralateral hippocampus.CONCLUSIONSSCF + G-CSF treatment in the subacute phase of TBI restored TBI-impaired spatial learning and memory, prevented posttraumatic anxiety and risk-taking behavior, inhibited TBI-induced neurodegeneration, and enhanced neural network remodeling. These findings suggest the therapeutic potential of hematopoietic growth factors for brain repair in the subacute phase of TBI.

Neuroprotective effects of Hemocoagulase Agkistrodon on experimental traumatic brain injury

Effects of Hydroxysafflor Yellow A on the Experimental Traumatic Brain Injury in Rats.

The Role of Crocetin in Protection Following Cerebral Contusion and in the Enhancement of Angiogenesis in Rats.

Neuroprotective Effect of Erythropoiet in Treatment of Traumatic Brain Injury in Rats

Effect of Hemocoagulase Agkistrodon on Coagulation Status in Patients with Traumatic Brain Injury in Vitro

Dynamic Changes and Effects of H2S, IGF-1, and GH in the Traumatic Brain Injury

Bloodletting Puncture at Hand Twelve Jing-Well Points Improves Neurological Recovery by Ameliorating Acute Traumatic Brain Injury-Induced Coagulopathy in Mice

Abietic acid ameliorates neuroinflammation and blood-brain barrier disruption in traumatic brain injury by inhibiting MAPK pathway

Neuroprotective Effects of NAAG Peptidase Inhibition on the Treatment of Traumatic Brain Injury

[Gly14]-Humanin Reduces Histopathology and Improves Functional Outcome after Traumatic Brain Injury in Mice.

Bioactive Hydrogel Synergizes Neuroprotection, Macrophage Polarization, and Angiogenesis to Improve Repair of Traumatic Brain Injury

Agmatine Attenuates Brain Edema and Apoptotic Cell Death after Traumatic Brain Injury

Brain repair by hematopoietic growth factors in the subacute phase of traumatic brain injury

[Gly14]-Humanin Offers Neuroprotection Through Glycogen Synthase Kinase-3Β Inhibition in a Mouse Model of Intracerebral Hemorrhage

Honokiol Reduces Mitochondrial Dysfunction and Inhibits Apoptosis of Nerve Cells in Rats with Traumatic Brain Injury by Activating the Mitochondrial Unfolded Protein Response

Human Amniotic Epithelial Stem Cells Inhibit Microglia Activation Through Downregulation of Tumor Necrosis Factor-Α, Interleukin-1Β and Matrix Metalloproteinase-12 in Vitro and in a Rat Model of Intracerebral Hemorrhage.

Effect Of Hydrogen-Rich Water On The Angiogenesis In Lesion Boundary Brain Tissue Of Traumatic Brain Injury-Challenged Rats

Inhibiting Endogenous Tissue Plasminogen Activator Enhanced Neuronal Apoptosis and Axonal Injury after Traumatic Brain Injury

Upregulation of C Terminus of Hsc70-Interacting Protein Attenuates Apoptosis and Procoagulant Activity and Facilitates Brain Repair after Traumatic Brain Injury

The Beta-Lactam Antibiotic, Ceftriaxone, Provides Neuroprotective Potential Via Anti-Excitotoxicity and Anti-Inflammation Response in a Rat Model of Traumatic Brain Injury

Neuroprotective Effect of [Gly14]-Humanin in Rats with Intracerebral Hemorrhage